This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
1. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002; 298:1912–1934.
Kostich M, English J, Madison V, Gheyas F, Wang L, Qiu P, Greene J, Laz TM. Human members of the eukaryotic protein kinase family. Genome Biol. 2002; 3: RESEARCH0043.
3. Wolstencroft KJ, Stevens R, Tabernero A, Brass, A. PhosphaBase: An ontology-driven database resource for protein phosphatases. Proteins Structure Function Bioinformatics. 2004; 58:290–294.
4. Pelech SL. Kinase profiling: The mysteries unraveled. Future Pharmaceuticals. 2006; 1:23–25.
5. Mukherji M. Phosphoproteomics in analyzing signaling pathways. Expert Rev Proteomics. 2005; 2:117–128.
Via MC. Kinases: From targets to therapeutics. Cambridge Health Institutes Insight Reports. 2003; 1–124.
7. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics. 2002; 1:323–333.
8. Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H, Kewson D, Shibuya TY, Lonardo F, Tainsky MA. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res. 2002; 8:3910–3921.
9. Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature. 1970; 227:680–685.
10. Burnette WN. “Western blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981; 112:195–203.
11. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975; 250:4007–4021.
12. Celis JE, Østergaard M, Jensen NA, Gromova I, Rasmussen HH, Gromov P. Human and mouse proteomic databases: Novel resources in the protein universe. FEBS Letters. 1998; 430:64–72.
13. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422:198–207.
14. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. (2000) Proc Natl Acad Sci USA. 2000; 97:9390–9395.
15. Bose R, Molina H, Patterson AS, Bitok JK, Periaswamy B, Bader JS, Pandey A, Cole PA. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci USA. 2006; 103:9773–9778.
16. Annan RS, Huddleston MJ, Verma R, Deshaies RJ, Carr SA. A multidimensional electrospray MS-based approach to phosphopeptide mapping. Anal Chem. 2001; 73:393–404.
17. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, Hunt DF, White FM. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol. 2002; 20:301–305.
18. Hunter T. The Croonian Lecture 1997. Philos Trans R Soc Lond B Biol Sci. 1998; 353:583–605.
19. Maguire PB, Wynne KJ, Harney DF, O'Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome. Proteomics. 2002; 2:642–648.
20. Gronborg M, Kristiansen TZ, Stensballe A, Andersen JS, Ohara O, Mann M, Jensen ON, Pandey A. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: Identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics. 2002; 1:517–527.
21. Wingren C, Borrebaeck CA. High-throughput proteomics using antibody microarrays. Expert Rev Proteomics. 2004; 1:355–364.
22. Borrebaeck CA. Antibody microarray-based oncoproteomics. Expert Opin Biol Ther. 2006; 6:833–838.
23. Hudelist G, Pacher-Zavisin M, Singer CF, Holper T, Kubista E, Schreiber M, Manavi M, Bilban M, Czerwenka K. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res Treat. 2004; 86:281–291.
24. Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT, Krajnik KL, Stenson MJ, Melhem MF, Novak AJ, Ansell SM, Witzig TE. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood. 2005; 105:3722–3730.
25. Kopf E, Shnitzer D, Zharhary D. Panorama Ab Microarray Cell Signaling kit: a unique tool for protein expression analysis. Proteomics. 2005; 5:2412–2416.
26. Smith L, Watson MB, O'Kane SL, Drew PJ, Lind MJ, Cawkwell L. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther. 2006; 5:2115–2120.
27. Usui-Aoki K, Shimada K, Nagano M, Kawai M, Koga H. A novel approach to protein expression profiling using antibody microarrays combined with surface plasmon resonance technology. Proteomics. 2005; 5:2396–2401.
28. Pelech S. Dimerization in protein kinase signaling. J Biol. 2006; 5:12.
29. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003; 284:31–53.
30. Holbro T, Hynes NE. ErbB receptors: Directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol. 2004; 44:195–217.
31. Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006; 7:505–516.
32. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006; 366:2–16.
33. Lin CR, Chen WS, Kruiger W, Stolarsky LS, Weber W, Evans RM, Verma IM, Gill GN, Rosenfeld MG. Expression cloning of human EGF receptor complementary DNA: Gene amplification and three related messenger RNA products in A431 cells. Science. 1984; 224:843–848.
34. Merlino GT, Xu YH, Ishii S, Clark AJ, Semba K, Toyoshima K, Yamamoto T, Pastan I. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science. 1984; 224:417–419.
35. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 1984; 309:418–425.
36. Helseth E, Dalen A, Unsgaard G, Vik E, Helseth A. Overexpression of the epidermal growth factor receptor gene in a human carcinoma cell line, derived from a brain metastasis. J Neuro-Oncology. 1989; 7:81–88.
37. Gulli LF, Palmer KC, Chen YQ, Reddy KB. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ. 1996; 7:173–178.
38. Smida Rezgui S, Honore S, Rognoni JB, Martin PM, Penel C. Up-regulation of alpha 2 beta 1 integrin cell-surface expression protects A431 cells from epidermal growth factor-induced apoptosis. Int J Cancer. 2000; 87:360–367.
39. Wu SL, Kim J, Hancock WS, Karger B. Extended Range Proteomic Analysis (ERPA): A new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). J Proteome Res. 2005; 4:1155–1170.
40. Wu SL, Kim J, Bandle RW, Liotta L, Petricoin E, Karger BL. Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA). Mol Cell Proteomics. 2006; 5:1610–1627.
41. Blagoev B, Ong SE, Kratchmarova I, Mann M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol. 2004; 22:1139–1145.
42. Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF 3rd, Liotta LA. Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods. 2004; 290:121–133.
43. Pelech S, Sutter C, Zhang, H. Kinetworks™ protein kinase multiblot analysis. Methods Mol Biol: Cancer Cell Signaling: Methods and Protocols (Terrian, D.M, ed.) 2003; 218:99–111.
44. Zhang H, Shi X, Hampong M, Paddon H, Dai W, Pelech SL. Polo-like kinase regulation of centrosomes is mediated through Serine 4 phosphorylation of B23/nucleophosmin. J Biol Chem. 2004; 279:35726–35734.
Acknowledgements
This work was supported by a grant from the Canadian Institutes for Health Research to SP and a grant from the National Research Council of Canada Industrial Research Assistance Program to Kinexus.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this chapter
Cite this chapter
Pelech, S., Zhang, H. (2008). Antibody-Based Proteomics Analysis of Tumor Cell Signaling Pathways. In: Bronchud, M.H., Foote, M.A., Giaccone, G., Olopade, O., Workman, P. (eds) Principles of Molecular Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-470-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-470-4_6
Publisher Name: Humana Press
Print ISBN: 978-1-934115-25-1
Online ISBN: 978-1-59745-470-4
eBook Packages: MedicineMedicine (R0)